Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Recruiting

Phase 2

Phase 3

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Sponsor:

Janssen Research & Development, LLC

Code:

NCT04119050

Conditions

Warm Autoimmune Hemolytic Anemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

M281

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Janssen Research & Development, LLC on 2025-05-23.